( July 9, 2026, 7:59 AM EDT) -- NEW ORLEANS — The en banc Fifth Circuit U.S. Court of Appeals will hear oral argument on Sept. 9 in a review of a panel ruling that granted Louisiana’s motion to stay the U.S. Food and Drug Administration’s 2023 decision that removed the in-person dispensing requirement for mifepristone, one of two drugs used to induce early termination of pregnancy, after the U.S. Supreme Court put the decision on hold....